NDC62175-0128-37 — ISOSORBIDE MONONITRATE EXTENDED-

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC62175-0128-37: ISOSORBIDE MONONITRATE EXTENDED-.

ISOSORBIDE MONONITRATE EXTENDED-. Key specifications include administration: ORAL, coating_feature: FILM, NONENTERIC, long_action_method: EXTENDED RELEASE, primary_container_type: BOTTLE, PLASTIC, supplementary_features: CARDIOVASCULAR USE, primary_container_content_quantity: 100.000 TABLETS. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-510-2359, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC62175-0128-37

NSN: 6505-01-510-2359
FSC: 6505 — Drugs and Biologicals
CAGE: 3L8K2 — KREMERS URBAN, LLC DBA SCHWARZ PHARMA MANUFACTURING (USA)

SPECIFICATIONS

administration	ORAL
coating_feature	FILM, NONENTERIC
special_features	EXTENDED RELEASE TABLETS, FOR THE PREVENTION OF ANGINA PECTORIS DUE TO CORONARY DISEASE; ONCE PER DAY DOSING; STORE AT ROOM TEMP.; PROTECT FROM EXCESSIVE MOISTURE
long_action_method	EXTENDED RELEASE
primary_container_type	BOTTLE, PLASTIC
supplementary_features	CARDIOVASCULAR USE
total_primary_container_quantity	1
primary_container_content_quantity	100.000 TABLETS
active_medicament_medicinal_strength	30.000 MILLIGRAMS ISOSORBIDE MONONITRATE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	ISOSORBIDE MONONITRATE EXTENDED RELEASE TABS 30MG 100S
american_hospital_formulary_service_classification_number	241208
NSN	6505-01-510-2359

COMPONENT DIAGRAM

KEY FEATURES

•

LONG ACTION METHOD: EXTENDED RELEASE

•

ADMINISTRATION: ORAL

•

COATING FEATURE: FILM, NONENTERIC

•

PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS

•

SUPPLEMENTARY FEATURES: CARDIOVASCULAR USE

•

PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC

TECHNICAL CHARACTERISTICS

LONG ACTION METHOD	EXTENDED RELEASE
ADMINISTRATION	ORAL
COATING FEATURE	FILM, NONENTERIC
PRIMARY CONTAINER CONTENT QUANTITY	100.000 TABLETS
SUPPLEMENTARY FEATURES	CARDIOVASCULAR USE
PRIMARY CONTAINER TYPE	BOTTLE, PLASTIC
SPECIAL FEATURES	EXTENDED RELEASE TABLETS, FOR THE PREVENTION OF ANGINA PECTORIS DUE TO CORONARY DISEASE; ONCE PER DAY DOSING; STORE AT ROOM TEMP.; PROTECT FROM EXCESSIVE MOISTURE
PART NAME ASSIGNED BY CONTROLLING AGENCY	ISOSORBIDE MONONITRATE EXTENDED RELEASE TABS 30MG 100S
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER	241208
ACTIVE MEDICAMENT MEDICINAL STRENGTH	30.000 MILLIGRAMS ISOSORBIDE MONONITRATE ACTIVE INGREDIENT

SUBSTITUTES & CROSS-REFERENCES 1

03-1256Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC62175-0128-37?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC62175-0128-37?

NDC62175-0128-37 is a ISOSORBIDE MONONITRATE EXTENDED-.

What parts can replace NDC62175-0128-37?

There is 1 known substitute for NDC62175-0128-37: 03-1256. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC62175-0128-37?

NDC62175-0128-37 is cataloged in the U.S. Government catalog under NSN 6505-01-510-2359. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC62175-0128-37 — ISOSORBIDE MONONITRATE EXTENDED-

Request a Quote — NDC62175-0128-37